Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

L. Platt; J. Reed; S. Minozzi; P. Vickerman; H. Hagan; C. French; A. Jordan; L. Degenhardt; V. Hope; S. Hutchinson; L. Maher; N. Palmateer; A. Taylor; M. Hickman

doi:10.1002/14651858.CD012021

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

L. Platt, J. Reed, S. Minozzi, P. Vickerman, H. Hagan, C. French, A. Jordan, L. Degenhardt, V. Hope, S. Hutchinson, L. Maher, N. Palmateer, A. Taylor, M. Hickman

SHLS School Office

Research output: Contribution to journal › Article

69 Downloads (Pure)

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To assess the impact of needle/syringe programmes with and without opiate substitution th erapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).
2. To assess the effect of OST alone on the incidence of HCV infection among PWID.

Original language	English
Article number	CD012021
Journal	Cochrane Database of Systematic Reviews
Issue number	1
Early online date	12 Jan 2016
DOIs	https://doi.org/10.1002/14651858.CD012021
Publication status	Published - Jan 2016

Keywords

opiate substitution therapy
HCV transmission

Documents and Links

10.1002/14651858.CD012021

Platt, L et al (2016) Cochrane Database of Systematic Reviews Issue 1. Art. No.: CD012021
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This is the final publisher version of the article published in: Cochrane Database of Systematic Reviews 2016, Issue 1. Art. No.: CD012021 available online at: https://doi.org/10.1002/14651858.CD012021
Final published version, 209 KB

Fingerprint Dive into the research topics of 'Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)'. Together they form a unique fingerprint.

Cite this

Platt, L., Reed, J., Minozzi, S., Vickerman, P., Hagan, H., French, C., Jordan, A., Degenhardt, L., Hope, V., Hutchinson, S., Maher, L., Palmateer, N., Taylor, A., & Hickman, M. (2016). Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol). Cochrane Database of Systematic Reviews , (1), [CD012021]. https://doi.org/10.1002/14651858.CD012021

Platt, L. ; Reed, J. ; Minozzi, S. ; Vickerman, P. ; Hagan, H. ; French, C. ; Jordan, A. ; Degenhardt, L. ; Hope, V. ; Hutchinson, S. ; Maher, L. ; Palmateer, N. ; Taylor, A. ; Hickman, M. / Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol). In: Cochrane Database of Systematic Reviews . 2016 ; No. 1.

@article{db840ec2253e4becbe9d9f35caa4d0e6,

title = "Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows:1. To assess the impact of needle/syringe programmes with and without opiate substitution th erapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).2. To assess the effect of OST alone on the incidence of HCV infection among PWID.",

keywords = "opiate substitution therapy, HCV transmission",

author = "L. Platt and J. Reed and S. Minozzi and P. Vickerman and H. Hagan and C. French and A. Jordan and L. Degenhardt and V. Hope and S. Hutchinson and L. Maher and N. Palmateer and A. Taylor and M. Hickman",

note = "Publisher permits VoR Funding: European Commission Drug Prevention and Information Programme (DIPP) Grant “Treatment as Prevention in Europe:Model Projections of Impact And Strengthening Evidence Base On Intervention Coverage and Effect and HCV Morbidity”. [JUST/2013/DPIP/AG/4812], Other.• National Institutes of Health/ National Institute on Drug Abuse (NIDA), USA.Holly Hagan, Ashl y Jordan and Jennifer Reed are supported by NIH-NIDA grant [1 R01 DA034637]• National Institute of Health Research (NIHR), UK.Clare French was funded by the NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol (grantnumber: HPRU-2012-10026). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, theDepartment of Health or Public Health England.• Lisa Maher is supported by an Australian National Health and Medical Research Council Senior Research Fellowship, Australia.",

year = "2016",

month = jan,

doi = "10.1002/14651858.CD012021",

language = "English",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "Cochrane Collaboration ",

number = "1",

}

Platt, L, Reed, J, Minozzi, S, Vickerman, P, Hagan, H, French, C, Jordan, A, Degenhardt, L, Hope, V, Hutchinson, S, Maher, L, Palmateer, N, Taylor, A & Hickman, M 2016, 'Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)', Cochrane Database of Systematic Reviews , no. 1, CD012021. https://doi.org/10.1002/14651858.CD012021

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol). / Platt, L.; Reed, J.; Minozzi, S.; Vickerman, P.; Hagan, H.; French, C.; Jordan, A.; Degenhardt, L.; Hope, V.; Hutchinson, S.; Maher, L.; Palmateer, N.; Taylor, A.; Hickman, M.

In: Cochrane Database of Systematic Reviews , No. 1, CD012021, 01.2016.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs (Protocol)

AU - Platt, L.

AU - Reed, J.

AU - Minozzi, S.

AU - Vickerman, P.

AU - Hagan, H.

AU - French, C.

AU - Jordan, A.

AU - Degenhardt, L.

AU - Hope, V.

AU - Hutchinson, S.

AU - Maher, L.

AU - Palmateer, N.

AU - Taylor, A.

AU - Hickman, M.

N1 - Publisher permits VoR Funding: European Commission Drug Prevention and Information Programme (DIPP) Grant “Treatment as Prevention in Europe:Model Projections of Impact And Strengthening Evidence Base On Intervention Coverage and Effect and HCV Morbidity”. [JUST/2013/DPIP/AG/4812], Other.• National Institutes of Health/ National Institute on Drug Abuse (NIDA), USA.Holly Hagan, Ashl y Jordan and Jennifer Reed are supported by NIH-NIDA grant [1 R01 DA034637]• National Institute of Health Research (NIHR), UK.Clare French was funded by the NIHR Health Protection Research Unit in Evaluation of Interventions at University of Bristol (grantnumber: HPRU-2012-10026). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, theDepartment of Health or Public Health England.• Lisa Maher is supported by an Australian National Health and Medical Research Council Senior Research Fellowship, Australia.

PY - 2016/1

Y1 - 2016/1

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows:1. To assess the impact of needle/syringe programmes with and without opiate substitution th erapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).2. To assess the effect of OST alone on the incidence of HCV infection among PWID.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows:1. To assess the impact of needle/syringe programmes with and without opiate substitution th erapy (OST) on the incidence ofHCV infection among people who inject drugs (PWID).2. To assess the effect of OST alone on the incidence of HCV infection among PWID.

KW - opiate substitution therapy

KW - HCV transmission

U2 - 10.1002/14651858.CD012021

DO - 10.1002/14651858.CD012021

M3 - Article

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 1

M1 - CD012021

ER -